Xiubao Ren
Tianjin University(CN)Shanxi Medical University(CN)Shanxi University(CN)Tianjin Medical University Cancer Institute and Hospital(CN)Huaian First People’s Hospital(CN)Henan Energy & Chemical Industry Group (China)(CN)Tianjin Huanhu Hospital(CN)Istituto Oncologico Veneto(IT)Shanxi Taiyuan Jinkang Rheumatism Hospital(CN)Qi2(US)Zhongshan Hospital of Xiamen University(CN)National Clinical Research(US)Istituti di Ricovero e Cura a Carattere Scientifico(IT)Tianjin haihe hospital(CN)Tianjin Medical University(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, Lung Cancer Treatments and Mutations, Immunotherapy and Immune Responses, Immune cells in cancer
Most-Cited Works
- → Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis(2015)1,097 cited
- → Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis(2008)915 cited
- → Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer(2013)599 cited
- → Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial(2020)492 cited
- → Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells(2018)473 cited
- → Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer